Intravenous Esketamine on Prevention of Postoperative Depression in Patients Undergoing Cardiac Surgery
Status:
Recruiting
Trial end date:
2022-12-15
Target enrollment:
Participant gender:
Summary
Esketamine is a general anesthetic with anti-depressant effects at subanaesthetic doses. This
study hypothesized that intraoperative administration of ketamine would prevent or mitigate
postoperative depressive symptoms in surgical patients.